You are viewing: US Elastomeric Infusion Pumps Market analysis

The US Elastomeric Infusion Pumps Market was valued at $503.8 Million in 2025 and projected to reach to $660 Million by 2030, representing a compound annual growth rate of 5.6%. The US elastomeric infusion pumps market is poised for steady growth through 2030, driven by increasing prevalence of chronic diseases requiring continuous drug delivery and rising adoption of home-based care models.

US Elastomeric Infusion Pumps Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Elastomeric Infusion Pumps Market Trends and Insights

  • The US market benefits from advanced healthcare infrastructure, high adoption of innovative drug delivery systems, and strong demand for portable infusion solutions across hospitals and home care settings.
  • In the US, elastomeric pumps are increasingly preferred for their ease of use, cost-effectiveness, and ability to deliver consistent medication dosing over extended periods. Driving growth in the US market are rising prevalence of chronic diseases, expanding geriatric populations requiring continuous medication delivery, and growing preference for patient-centric home-based care models.
  • The US healthcare system's emphasis on reducing hospital readmissions and improving patient outcomes has accelerated elastomeric pump adoption.
  • Between 2025 and 2030, the US market will continue to benefit from technological advancements, regulatory support, and increased reimbursement coverage for infusion therapies..

Key Market Statistics

  • CAGR (2025-2030) 5.6% CAGR
  • Market Size, 2025 ~USD 503.8 Million
  • Forecast, 2030 ~USD 660 Million
  • Country US

US Elastomeric Infusion Pumps Market Overview

Market Valuation :

The US elastomeric infusion pumps market is valued at $503.8 million in 2025, demonstrating strong market maturity and established healthcare adoption across the country.

Growth Trajectory :

With a CAGR of 5.6% through 2030, the US market is expanding faster than the global average of 5.3%, reflecting accelerating demand for advanced drug delivery solutions.

Healthcare Infrastructure Advantage :

Advanced US healthcare infrastructure, coupled with high adoption rates of innovative drug delivery systems, drives sustained market growth in both hospital and home care environments.

Portable Solutions Demand :

Strong demand for portable infusion solutions across US hospitals and home care settings is fueling market expansion, particularly as patient preference shifts toward mobility and convenience.

US Elastomeric Infusion Pumps Market Dynamics

  • Healthcare providers are increasingly investing in portable infusion technologies to improve patient outcomes and reduce hospital readmissions.
  • The market benefits from robust reimbursement policies, strong FDA approval pathways, and continuous innovation in pump design and functionality.
  • Expansion in oncology, pain management, and antibiotic therapies further supports market growth.
  • Key drivers include aging demographics, technological advancements, and growing preference for patient-centric care delivery solutions across diverse healthcare settings..

Related Ecosystem

Key Takeaways

  • The US elastomeric infusion pumps market is valued at $503.8 million in 2025 and will reach $660.0 million by 2030, growing at 5.6% CAGR.
  • The US market is driven by chronic disease prevalence, aging populations, and the shift toward home-based care delivery models.
  • Advanced healthcare infrastructure and strong reimbursement policies in the US support accelerated adoption of elastomeric infusion technologies.
  • The US market benefits from continuous innovation in pump design, improved patient compliance, and expanding clinical applications through 2030.

Elastomeric Infusion Pumps Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (Setting)
Forecast Period 2025–2030
Growth Rate CAGR of 5.3% from 2025 to 2030
Largest Segment ACCESSORIES AND CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.15 (2025)
Revenue Forecast (Billions) ~USD 1.49 (2030)
Segments Covered Type, Application, End-Use Industry, Product, Setting

US Elastomeric Infusion Pumps Market Report Segmentation

5 segment dimensions are covered across the global market.

By Type

  • Continuous Rate
  • Variable Rate

By Application

  • Analgesia/Pain Management
  • Antibiotics
  • Chemotherapy
  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Hematology
  • Other Applications
  • Pain Management
  • Pediatrics/Neonatology

By End-Use Industry

  • Ambulatory Surgical Centers (Ascs)
  • Homecare Settings
  • Hospitals
  • Other End-Use Industries

By Product

  • Accessories And Consumables
  • Devices

By Setting

  • Academic And Research Institutes
  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals

US: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030

Segment20232024202520262027202820292030CAGR (%)
AMBULATORY SURGICAL CENTERS (ASCS)114.3119.3125.9132.9140.3148.1156.3164.95.5
HOMECARE SETTINGS104.7109.8116.4123.4130.9138.8147.2156.16
HOSPITALS210.7220.5232.4244.9258271.9286.5301.85.4
OTHER END-USE INDUSTRIES26.727.729.130.532.133.735.437.25
TOTAL456.4477.2503.8531.8561.3592.5625.36605.6

Target Audience

  • Medical Device Manufacturers : Manufacturers need US-specific market data to benchmark competitive positioning, identify growth segments, and develop targeted product strategies for the elastomeric pump market.
  • Healthcare Providers & Hospital Systems : Hospital administrators and procurement teams require market insights to evaluate infusion pump technologies, assess vendor options, and optimize drug delivery infrastructure investments.
  • Pharmaceutical Companies : Pharma firms need market intelligence on infusion pump adoption rates and home care trends to align drug delivery strategies and identify partnership opportunities with pump manufacturers.
  • Investment & Private Equity Firms : Investors require detailed US market forecasts, growth drivers, and competitive analysis to evaluate acquisition targets and assess return potential in the elastomeric pump sector.
  • Healthcare Consultants & Analysts : Consulting firms and research analysts need comprehensive US market data to support client advisory services, market assessments, and strategic planning in medical device and healthcare sectors.

Key Companies in the US Elastomeric Infusion Pumps Market

CompanyHQOwnershipStrongest segments
BAXTERUnited StatesPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
NIPROJapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
AVNSUnited StatesPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
WOOYOUNG MEDICAL CO., LTD.South KoreaPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent),
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.ChinaPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps,
AMBU A/SDenmarkPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
DAIKEN MEDICAL CO., LTD.JapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications,

BAXTER

Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.

AVNS

AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.

WOOYOUNG MEDICAL CO., LTD.

Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.

SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.

Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.

AMBU A/S

Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.

DAIKEN MEDICAL CO., LTD.

Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.

Reasons to Buy this Report

  • Market Size & Growth Data : Access precise US market valuation ($503.8M in 2025) and forecast projections ($660M by 2030) with 5.6% CAGR to inform strategic investment and expansion decisions.
  • Competitive Landscape Intelligence : Understand market dynamics specific to the US healthcare system, including key players, market share distribution, and competitive positioning within the elastomeric pump segment.
  • Segment & Application Analysis : Identify high-growth segments within the US market including hospital infusion, home care delivery, oncology applications, and pain management to target profitable opportunities.
  • Regulatory & Reimbursement Insights : Gain clarity on FDA approval pathways, insurance coverage policies, and reimbursement trends specific to US elastomeric infusion pumps to navigate market entry and pricing strategies.
  • Strategic Growth Opportunities : Discover emerging trends in portable infusion technology, home healthcare adoption, and patient-centric care models driving US market expansion for informed business development.

Frequently asked questions

What is the current size of the US elastomeric infusion pumps market?

The US elastomeric infusion pumps market is valued at $503.8 million in 2025 and is expected to grow to $660.0 million by 2030.

What is the projected growth rate for the US market?

The US elastomeric infusion pumps market is projected to grow at a CAGR of 5.6% from 2025 to 2030.

What factors are driving growth in the US elastomeric infusion pumps market?

Key drivers in the US include rising chronic disease prevalence, an aging population, increased adoption of home-based care, strong healthcare infrastructure, and improved reimbursement policies.

Why are elastomeric pumps preferred in the US healthcare system?

In the US, elastomeric pumps are preferred for their portability, ease of use, cost-effectiveness, consistent drug delivery, and ability to reduce hospital readmissions through home care applications.

What is the forecast market size for the US by 2030?

The US elastomeric infusion pumps market is forecasted to reach $660.0 million by 2030, representing significant growth from the 2025 baseline of $503.8 million.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is the breakdown of primary respondents:

Elastomeric Infusion Pumps Market

Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

Elastomeric Infusion Pumps Market

Data Triangulation

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.

Stakeholders

  • Elastomeric infusion pump manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the global elastomeric infusion pumps market, based on type, end-use industry, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, expansions, partnerships, and agreements in the elastomeric infusion pumps market
  • To provide the impact of AI/Gen AI on the market

Get the Full Elastomeric Infusion Pumps Market Report

Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status